ConductScience.org, home

Trial · NCT04171570

Registered outcomes13

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryForearm radial artery occlusion (RAO) rate before dischargeup to 5 daysForearm radial artery occlusion (RAO) rate before discharge measured with Doopler Ultrasound
SecondaryRate of successful sheath insertionup to 2 daysRate of successful sheath insertion obtained though eCRF question
SecondaryRate of access site crossoverup to 2 daysRate of access site crossover - if the initial access point fails physician can perform the procedure using other access site of his/her choice This data point is captured on the eCRF
SecondaryTotal procedural timeup to 2 daysTotal procedural time defined as the time between initiation of local anesthesia to sheath removal - information captured on the eCRF
SecondarySheath insertion timeup to 2 daysSheath insertion time recorded in the eCRF and defined as when puncture with the introducer needle first attempted until the time when introducer sheath is successfully inserted
SecondaryPuncture site bleeding according to EASY criteriaup to 5 daysPuncture site bleeding according to EASY criteria
SecondaryOverall bleeding according to BARC criteriaup to 5 daysOverall bleeding according to BARC criteria
SecondaryVascular access-site complicationup to 5 days
Vascular access-site complication documented on the eCRF. It is composed by the rate of vessel perforation after occlusion requiring intervention, arterial dissection, pseudoaneurysm, and local haematoma
SecondaryRate of radial artery spasmup to 2 days
Rate of radial artery spasm captured in the eCRF. Radial arety spasm is defined as an inability to manipulate the guidewire or catheter in a smooth and pain-free manner and also as an inability to remove the sheath in a similar way at the end of the procedure
SecondaryRate of distal radial artery occlusion (dRAO)up to 5 daysRate of distal radial artery occlusion (dRAO) by doopler ultrasound and capture in the eCRF
SecondaryPatent hemostasis was achieved or not (CTRA) by reverse barbeau testup to 5 daysPatent hemostasis was achieved or not (CTRA) by reverse barbeau test
SecondaryTime required to reach hemostasisup to 5 daysTime required to reach hemostasis, captured on the eCRF and defined as the time between sheath removal to complete hemostasis
SecondaryPain associated with the procedure: Visual Assessment Scale (VAS)up to 5 days
Pain associated with the procedure measured by the Visual Assessment Scale (VAS), a numeric rating scale. VAS is a 10 cm line with anchor statements on the left (no pain = 0) and on the right (worst possible pain = 10)

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04171570/registered